Testing effectiveness (Phase 2)Ended earlyNCT04517435What this trial is testingME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Deepa Jagadeesh 13
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)WithdrawnNCT02973191What this trial is testingDetermine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic LeukemiaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Celgene
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Testing effectiveness (Phase 2)WithdrawnNCT02371590What this trial is testingLenalidomide and Obinutuzumab for Previously Untreated CLLWho this might be right forChronic Lymphocytic Leukemia University of California, San Diego
Testing effectiveness (Phase 2)Ended earlyNCT00003113What this trial is testingOral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's LymphomasWho this might be right forLymphoma Case Comprehensive Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT04049513What this trial is testingENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)Who this might be right forLymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more Malaghan Institute of Medical Research 30
Large-scale testing (Phase 3)UnknownNCT00499018What this trial is testingDose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell LymphomaIPI≥2 Fondazione Italiana Linfomi - ETS 399
Testing effectiveness (Phase 2)UnknownNCT02481310What this trial is testingCombination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAdult Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more Northwestern University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02756897What this trial is testingVenetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more M.D. Anderson Cancer Center 234
Testing effectiveness (Phase 2)Looking for participantsNCT06045910What this trial is testingA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell MalignanciesWho this might be right forLymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more Cancer Research UK 84
Testing effectiveness (Phase 2)Study completedNCT00051597What this trial is testingA Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesWho this might be right forHodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more Seagen Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT05272813What this trial is testingInvestigate the Efficacy and Safety of MS-553 in CLL/SLLWho this might be right forLymphocytic LeukemiaSmall Lymphocytic Lymphoma Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Early research (Phase 1)Active Not RecruitingNCT01430390What this trial is testingIn Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell MalignanciesWho this might be right forAcute Lymphocytic LeukemiaLymphoma Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07788118What this trial is testingA Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell LymphomaWho this might be right forRelapsed/Refractory Large B-cell Lymphoma (LBCL)Diffuse Large B-Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+2 more Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07674810What this trial is testingTrial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)UnknownNCT02767674What this trial is testingTrial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 258
Early research (Phase 1)Study completedNCT01373229What this trial is testingLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell David Rizzieri, MD 21
Early research (Phase 1)Active Not RecruitingNCT03283137What this trial is testingCombination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHLWho this might be right forCLLB-cell Non Hodgkin Lymphoma University of Chicago 20
Not applicableApproved For MarketingNCT04162756What this trial is testingStudy of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell MalignanciesWho this might be right forRelapse/Refractory Mantle Cell Lymphoma Kite, A Gilead Company